文献速递其他结缔组织病

系统性硬化症-混合性结缔组织病与重叠综合征的临床特征

Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-04-03

基于澳大利亚硬皮病队列1728例满足ACR/EULAR标准的SSc患者,比较SSc-MCTD、SSc重叠与单纯SSc三组的临床特征与生存。SSc-MCTD和重叠组更常见局限皮肤型、关节炎和肌炎,但ILD频率三组相似;SSc-MCTD生存更优但校正性别和发病年龄后不显著。抗着丝点或抗RNP抗体者生存优于抗Scl-70或抗RNA聚合酶III抗体者。

要点

  • SSc-MCTD患者更常见亚洲人且发病年龄更轻。
  • SSc重叠和SSc-MCTD中关节炎和肌炎更常见,但ILD频率与单纯SSc相似。
  • 抗着丝点或抗RNP抗体者生存优于抗Scl-70或抗RNA聚合酶III抗体者。

核心结论

  • 抗RNP抗体与SSc患者更好的生存相关,优于抗Scl-70和抗RNA聚合酶III抗体。
  • SSc-MCTD和SSc重叠患者诊断ILD和PAH后死亡率低于单纯SSc患者。

研究设计与样本

  • 澳大利亚硬皮病队列研究,纳入1728例满足ACR/EULAR标准的SSc患者。
  • 分为SSc-MCTD、SSc重叠和单纯SSc三组,采用方差分析或卡方检验比较临床特征,Kaplan-Meier曲线和Cox比例风险回归模型进行生存分析。

主要发现

  • 1728例中97例(5.6%)为SSc-MCTD,126例(7.3%)为SSc重叠。
  • SSc-MCTD患者亚洲人比例更高(18.3% vs SSc重叠10.1%和单纯SSc 3.6%,P<0.0001),发病年龄更轻(38.4岁 vs 46.5或46.8岁,P<0.0001)。
  • SSc-MCTD和SSc重叠更常见局限皮肤型SSc,三组ILD频率相似,SSc重叠中PAH较少见。
  • 关节炎和肌炎在SSc重叠和SSc-MCTD中比单纯SSc更常见。
  • Kaplan-Meier曲线显示SSc-MCTD生存优于SSc重叠或单纯SSc(P=0.011),但校正性别和发病年龄后不显著。

临床怎么用

  • 对SSc患者应检测SSc特异性抗体以协助预后判断,抗RNP或抗着丝点抗体提示生存较好。
  • SSc-MCTD和SSc重叠患者仍需关注ILD和PAH,尽管诊断后死亡率可能低于单纯SSc。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the clinical characteristics and outcomes of systemic sclerosis-mixed connective tissue disease (SSc-MCTD) and SSc overlap syndrome. METHODS: We included patients from the Australian Scleroderma Cohort Study who met American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for SSc. Three mutually exclusive groups were created: SSc-MCTD, SSc overlap, and SSc only. Univariate comparison of clinical features was performed by analysis of variance or chi-square test. Survival analysis was performed using Kaplan-Meier (KM) curves and Cox proportional hazards regression models. RESULTS: Of 1,728 patients, 97 (5.6%) had SSc-MCTD, and 126 (7.3%) had SSc overlap. Those with MCTD-SSc were more commonly Asian (18.3% versus 10.1% in SSc overlap, and 3.6% in SSc only; P < 0.0001) and younger at disease onset (38.4 years versus 46.5 or 46.8 years, P < 0.0001). Those with SSc-MCTD or SSc overlap were more likely to have limited cutaneous SSc. All 3 groups had similar frequency of interstitial lung disease (ILD), although pulmonary arterial hypertension (PAH) was less common in SSc overlap. Synovitis and myositis were more common in SSc overlap and SSc-MCTD than in SSc only. KM curves showed better survival in SSc-MCTD than SSc overlap or SSc only (P = 0.011), but this was not significant after adjustment for sex and age at disease onset. SSc-specific antibodies were survival prognostic markers, with antinuclear antibody centromere or anti-RNP conferring better survival than anti-Scl-70 or anti-RNA polymerase III (P = 0.005). Patients with SSc-MCTD and SSc overlap had lower mortality following diagnosis of ILD and PAH than patients with SSc only. CONCLUSION: This study provides insights into the clinical characteristics of patients with SSc-MCTD, SSc overlap, and SSc only and shows that anti-RNP antibodies are associated with better survival than anti-Scl-70 and anti-RNA polymerase III antibodies.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Fairley JL, Hansen D, Proudman S, et al. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes. Arthritis Care Res (Hoboken). 2021. PMID: 32058672. doi:10.1002/acr.24167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。